493 related articles for article (PubMed ID: 22671023)
1. Strategy of lipid recognition by invariant natural killer T cells: 'one for all and all for one'.
Mallevaey T; Selvanantham T
Immunology; 2012 Jul; 136(3):273-82. PubMed ID: 22671023
[TBL] [Abstract][Full Text] [Related]
2. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
Lawson V
Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
[TBL] [Abstract][Full Text] [Related]
3. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
Front Immunol; 2018; 9():1266. PubMed ID: 29928278
[TBL] [Abstract][Full Text] [Related]
4. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
5. Innate-like recognition of microbes by invariant natural killer T cells.
Kronenberg M; Kinjo Y
Curr Opin Immunol; 2009 Aug; 21(4):391-6. PubMed ID: 19646850
[TBL] [Abstract][Full Text] [Related]
6. How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens.
Brigl M; Brenner MB
Semin Immunol; 2010 Apr; 22(2):79-86. PubMed ID: 19948416
[TBL] [Abstract][Full Text] [Related]
7. Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.
Horst D; Geerdink RJ; Gram AM; Stoppelenburg AJ; Ressing ME
Viruses; 2012 Oct; 4(10):2379-99. PubMed ID: 23202469
[TBL] [Abstract][Full Text] [Related]
8. Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors.
Guo T; Chamoto K; Nakatsugawa M; Ochi T; Yamashita Y; Anczurowski M; Butler MO; Hirano N
PLoS One; 2016; 11(5):e0156114. PubMed ID: 27213277
[TBL] [Abstract][Full Text] [Related]
9. Discrete TCR Binding Kinetics Control Invariant NKT Cell Selection and Central Priming.
Cruz Tleugabulova M; Escalante NK; Deng S; Fieve S; Ereño-Orbea J; Savage PB; Julien JP; Mallevaey T
J Immunol; 2016 Nov; 197(10):3959-3969. PubMed ID: 27798168
[TBL] [Abstract][Full Text] [Related]
10. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
11. Activation strategies for invariant natural killer T cells.
Kohlgruber AC; Donado CA; LaMarche NM; Brenner MB; Brennan PJ
Immunogenetics; 2016 Aug; 68(8):649-63. PubMed ID: 27457886
[TBL] [Abstract][Full Text] [Related]
12. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
Front Immunol; 2020; 11():610010. PubMed ID: 33312179
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the SYK Tyrosine kinase expression to human iNKT self-reactivity.
Perroteau J; Navet B; Devilder MC; Hesnard L; Scotet E; Gapin L; Saulquin X; Gautreau-Rolland L
Eur J Immunol; 2020 Oct; 50(10):1454-1467. PubMed ID: 32460359
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.
López-Sagaseta J; Kung JE; Savage PB; Gumperz J; Adams EJ
PLoS Biol; 2012; 10(10):e1001412. PubMed ID: 23109910
[TBL] [Abstract][Full Text] [Related]
15. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
Cohen NR; Garg S; Brenner MB
Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
[TBL] [Abstract][Full Text] [Related]
16. iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo .
Bassiri H; Das R; Guan P; Barrett DM; Brennan PJ; Banerjee PP; Wiener SJ; Orange JS; Brenner MB; Grupp SA; Nichols KE
Cancer Immunol Res; 2014 Jan; 2(1):59-69. PubMed ID: 24563871
[TBL] [Abstract][Full Text] [Related]
17. New Genetically Manipulated Mice Provide Insights Into the Development and Physiological Functions of Invariant Natural Killer T Cells.
Ren Y; Sekine-Kondo E; Tateyama M; Kasetthat T; Wongratanacheewin S; Watarai H
Front Immunol; 2018; 9():1294. PubMed ID: 29963043
[TBL] [Abstract][Full Text] [Related]
18. Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor.
López-Sagaseta J; Sibener LV; Kung JE; Gumperz J; Adams EJ
EMBO J; 2012 Apr; 31(8):2047-59. PubMed ID: 22395072
[TBL] [Abstract][Full Text] [Related]
19. CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.
Florence WC; Bhat RK; Joyce S
Expert Rev Mol Med; 2008 Jul; 10():e20. PubMed ID: 18601810
[TBL] [Abstract][Full Text] [Related]
20. Invariant natural killer T cells: bridging innate and adaptive immunity.
Van Kaer L; Parekh VV; Wu L
Cell Tissue Res; 2011 Jan; 343(1):43-55. PubMed ID: 20734065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
